3.03
price up icon0.16%   0.05
 
loading
Schlusskurs vom Vortag:
$3.08
Offen:
$3.09
24-Stunden-Volumen:
91,866
Relative Volume:
0.56
Marktkapitalisierung:
$202.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.20M
KGV:
-
EPS:
-
Netto-Cashflow:
$57,000
1W Leistung:
-3.44%
1M Leistung:
-35.73%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$2.90
$3.1199
1-Wochen-Bereich:
Value
$2.90
$3.355
52-Wochen-Spanne:
Value
$2.90
$5.47

Climb Bio Inc Stock (CLYM) Company Profile

Name
Firmenname
Climb Bio Inc
Name
Telefon
1-866-857-2596
Name
Adresse
20 WILLIAM STREET, WELLESLEY HILLS
Name
Mitarbeiter
11
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CLYM's Discussions on Twitter

Vergleichen Sie CLYM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
CLYM 3.03 202.34M 0 -64.20M 57,000 0.00
VRTX 449.64 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.66 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 589.18 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 248.13 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.50 24.89B 3.30B -501.07M 1.03B 11.54

Climb Bio Inc Aktie (CLYM) Neueste Nachrichten

pulisher
12:33 PM

Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb Or Sink? - Barchart

12:33 PM
pulisher
Nov 20, 2024

Some Confidence Is Lacking In ABL Bio Inc. (KOSDAQ:298380) As Shares Slide 30% - Simply Wall St

Nov 20, 2024
pulisher
Nov 15, 2024

Are Wall Street Analysts Predicting KKR Stock Will Climb or Sink? - MSN

Nov 15, 2024
pulisher
Nov 14, 2024

Deep Track Capital, LP Reduces Stake in Climb Bio Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Are Business Services Stocks Lagging Climb Global Solutions, Inc. (CLMB) This Year? - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Sri Lankan Stocks Climb, Information Technology Leads The Way - Finimize

Nov 14, 2024
pulisher
Nov 13, 2024

Climb Bio Inc. Shifts Focus to Immune-Mediated Diseases - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

iBio Reports Fiscal First Quarter 2025 Financial Results - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Climb Bio Secures FDA Clearance for SLE Drug Trial, Reports $217.9M Cash Position | CLYM Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Climb Bio Appoints Biotech Veteran Douglas Williams as Board Chair, Strengthens Leadership | CLYM Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 06, 2024

Sales climb for EcoSynthetix Inc. in Q3 - Pulp & Paper Canada

Nov 06, 2024
pulisher
Oct 31, 2024

Climb Bio to Present at Upcoming Investor Conferences - GlobeNewswire

Oct 31, 2024
pulisher
Oct 30, 2024

Nasdaq Futures Climb on Upbeat Alphabet Results, U.S. GDP Data and More Big Tech Earnings on Tap - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

Humic Acid Market Set to Climb to USD 1.63 Billion by 2030 - openPR

Oct 30, 2024
pulisher
Oct 24, 2024

ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN

Oct 24, 2024
pulisher
Oct 23, 2024

Tevogen Bio (TVGN) Sees Major Stock Surge After Key AI Move - Stocks Telegraph

Oct 23, 2024
pulisher
Oct 19, 2024

Interpublic Group Of Cos., Inc. (IPG): Worth A Small Bite At $32.03 - Stocks Register

Oct 19, 2024
pulisher
Oct 18, 2024

Why Lamb Weston Stock Was Climbing Today - Yahoo Finance

Oct 18, 2024
pulisher
Oct 18, 2024

Big Bank Stocks Climb. 3 Stocks to Consider Adding to Your Portfolio. - Yahoo Finance

Oct 18, 2024
pulisher
Oct 18, 2024

Merck & Co’s Clesrovimab Has Beyfortus Hill To Climb In RSV - Citeline News & Insights

Oct 18, 2024
pulisher
Oct 17, 2024

Treasury Yields Climb as Strong Data Sow Doubt on Fed Rate Cuts - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Mortgage Demand Sees Sharpest Weekly Drop Since April 2020 As Rates Climb Above 6.5% - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Korean growth stocks climb after rate cut - 코리아타임스

Oct 17, 2024
pulisher
Oct 16, 2024

Vale Achieves Six-Year High in Iron Ore Output, Copper and Nickel Production Also Climb - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

European Wax Center Continues to Climb in Franchise Times' Top 400 Ranking - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

US Mortgage Rates Climb to 6.52%, Highest Since Early August - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

What You Need to Know Ahead of Bio-Techne's Earnings Release - TradingView

Oct 16, 2024
pulisher
Oct 15, 2024

Stocks of B. Riley Financial Inc (RILY) are poised to climb above their peers - SETE News

Oct 15, 2024
pulisher
Oct 15, 2024

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event - The Manila Times

Oct 15, 2024
pulisher
Oct 14, 2024

‘Retirement super pot’ holders pay themselves around £3m each in a year - Yahoo Finance UK

Oct 14, 2024
pulisher
Oct 12, 2024

Climb Bio to present kidney disease treatment study By Investing.com - Investing.com Australia

Oct 12, 2024
pulisher
Oct 12, 2024

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024 - GlobeNewswire

Oct 12, 2024
pulisher
Oct 11, 2024

Climb Bio to present kidney disease treatment study - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology - The Bakersfield Californian

Oct 11, 2024
pulisher
Oct 11, 2024

A stock that deserves closer examination: Climb Bio Inc. (CLYM) - US Post News

Oct 11, 2024
pulisher
Oct 10, 2024

Climb Global (CLMB) Surged on Strong Results - Yahoo Finance

Oct 10, 2024
pulisher
Oct 09, 2024

Quarterly IPOs Climb Back Above $1bn - Scrip

Oct 09, 2024
pulisher
Oct 09, 2024

US 30-Year Mortgage Rate Climbs by Most in More Than a Year - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Climb Global (CLMB) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance

Oct 08, 2024
pulisher
Oct 04, 2024

FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% - Baystreet.ca

Oct 04, 2024
pulisher
Oct 04, 2024

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - ForexTV.com

Oct 04, 2024
pulisher
Oct 04, 2024

Climb Bio to Present at William Blair’s Upcoming Conference - GlobeNewswire

Oct 04, 2024
pulisher
Oct 04, 2024

Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - The Manila Times

Oct 04, 2024
pulisher
Oct 03, 2024

Intumescent Coatings Market Size to Climb to USD 2.4 - GlobeNewswire

Oct 03, 2024
pulisher
Oct 03, 2024

Intumescent Coatings Market Size to Climb to USD 2.4 billion by 2034 with a 7.4% CAGR, Supported by Steel Fabrication Fireproofing Demand | States Transparency Market Research, Inc. - Yahoo Finance

Oct 03, 2024

Finanzdaten der Climb Bio Inc-Aktie (CLYM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Climb Bio Inc-Aktie (CLYM) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Morisset Valerie
EVP, R&D AND CSO
Jul 22 '24
Sale
8.03
69,005
554,170
31,317
Morisset Valerie
EVP, R&D AND CSO
Jul 19 '24
Sale
7.21
60,201
434,325
100,322
Morisset Valerie
EVP, R&D AND CSO
Jul 18 '24
Sale
6.93
38,576
267,332
160,523
Morisset Valerie
EVP, R&D AND CSO
Jul 17 '24
Sale
6.91
3,207
22,160
199,099
Morisset Valerie
EVP, R&D AND CSO
Jul 16 '24
Sale
7.13
50,000
356,500
202,306
Morisset Valerie
EVP, R&D AND CSO
Jul 12 '24
Sale
7.07
50,000
353,500
294,683
Morisset Valerie
EVP, R&D AND CSO
Jul 15 '24
Sale
7.01
42,377
297,063
252,306
Morisset Valerie
EVP, R&D AND CSO
Jul 11 '24
Sale
7.11
50,000
355,500
344,683
Morisset Valerie
EVP, R&D AND CSO
Jul 10 '24
Sale
6.83
50,000
341,500
394,683
Morisset Valerie
EVP, R&D AND CSO
Jul 09 '24
Sale
6.66
5,931
39,500
444,683
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):